Pathfinder Counseling Services Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2919 17th Ave Ste 110, Longmont, CO 80503 Phone: 303-651-6769 |
Mental Health Partners Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 529 Coffman St Ste 300, Longmont, CO 80501 Phone: 303-443-8500 |
Lifestance Health Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1630 Dry Creek Dr Ste 100b, Longmont, CO 80503 Phone: 970-310-3406 Fax: 888-965-4615 |
Connections-adolescent And Family Counseling, Llc Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 500 9th Ave Ste 1, Longmont, CO 80501 Phone: 970-315-2595 |
The Foundation Behavioral Services Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 2 James Cir, Longmont, CO 80501 Phone: 303-523-7573 |
Blaze Iom Reading, Pllc Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 1511 Onyx Cir, Longmont, CO 80504 Phone: 713-500-7128 |
News Archive
DZIF scientists from the University of Bonn have shown that not all conventional Zika virus molecular diagnostic tests for are sufficiently reliable. They developed optimised assays and a control for quantifying viruses in blood and urine.
British scientists have developed a tabletop DNA test laboratory that can cut the diagnosis of disease and infection from hours to 30 minutes. This new test laboratory will soon begin trials in UK hospitals.
Now on Capsules, KHN's news blog, the latest installment of Blogwatch - Andrew Villegas rounds up what bloggers are saying about what might be at stake for Medicare, Medicaid and the health law.
Double-stranded breaks in cellular DNA can trigger tumorigenesis. Researchers from Ludwig-Maximilians-Universitaet (LMU) in Munich have now determined the structure of a protein involved in the repair and signaling of DNA double-strand breaks. The work throws new light on the origins of neurodegenerative diseases and certain tumor types.
Adding a second agent may make a new, experimental anti-cancer drug effective against a wide range of cancers, researchers at the University of Illinois at Chicago College of Medicine have found.
› Verified 9 days ago